Business Description
Stryker Corp
NAICS : 339112
SIC : 3841
ISIN : US8636671013
Share Class Description:
LTS:0R2S: Ordinary SharesCompare
Compare
Traded in other countries / regions
SYK.USAS1YK34.BrazilSYK.MexicoSYK.GermanySYK.Austria1SYK.Italy0R2S.UK IPO Date
2014-11-04Description
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 2.63 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.05 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.3 | |||||
| 3-Year EBITDA Growth Rate | 17 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | 3.7 | |||||
| 3-Year Book Growth Rate | 12 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.12 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.57 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 0.97 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 222.21 | |||||
| Days Sales Outstanding | 60.83 | |||||
| Days Payable | 67.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 9 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | 1.25 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.7 | |||||
| Operating Margin % | 19.06 | |||||
| Net Margin % | 15.44 | |||||
| FCF Margin % | 15.3 | |||||
| ROE % | 18.11 | |||||
| ROA % | 8.37 | |||||
| ROIC % | 10.59 | |||||
| ROC (Joel Greenblatt) % | 57.67 | |||||
| ROCE % | 12.6 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 39.69 | |||||
| Forward PE Ratio | 27.78 | |||||
| PE Ratio without NRI | 30.89 | |||||
| Shiller PE Ratio | 55.52 | |||||
| Price-to-Owner-Earnings | 38.46 | |||||
| PEG Ratio | 4.29 | |||||
| PS Ratio | 6.13 | |||||
| PB Ratio | 6.69 | |||||
| Price-to-Free-Cash-Flow | 40.07 | |||||
| Price-to-Operating-Cash-Flow | 33.87 | |||||
| EV-to-EBIT | 34.44 | |||||
| EV-to-EBITDA | 27.27 | |||||
| EV-to-Revenue | 6.56 | |||||
| EV-to-FCF | 42.9 | |||||
| Price-to-Projected-FCF | 2.88 | |||||
| Price-to-DCF (Earnings Based) | 1.74 | |||||
| Price-to-DCF (FCF Based) | 2.18 | |||||
| Price-to-Median-PS-Value | 1.25 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.28 | |||||
| Earnings Yield (Greenblatt) % | 2.9 | |||||
| FCF Yield % | 2.52 | |||||
| Forward Rate of Return (Yacktman) % | 9.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stryker Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20,498 | ||
| EPS (TTM) ($) | 8.25 | ||
| Beta | 0.07 | ||
| Volatility % | 0.48 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 276.39 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 276.39 - 276.39 | ||
| Shares Outstanding (Mil) | 380.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stryker Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stryker Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stryker Corp Frequently Asked Questions
What is Stryker Corp(LTS:0R2S)'s stock price today?
The current price of LTS:0R2S is $276.39. The 52 week high of LTS:0R2S is $276.39 and 52 week low is $276.39.
When is next earnings date of Stryker Corp(LTS:0R2S)?
The next earnings date of Stryker Corp(LTS:0R2S) is 2024-04-30.
Does Stryker Corp(LTS:0R2S) pay dividends? If so, how much?
Stryker Corp(LTS:0R2S) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers